首页> 外文学位 >Total solid-phase synthesis of the mixirins; antitumour cyclic lipopeptides.
【24h】

Total solid-phase synthesis of the mixirins; antitumour cyclic lipopeptides.

机译:Mixirins的全固相合成;抗肿瘤环状脂肽。

获取原文
获取原文并翻译 | 示例

摘要

Mixirins A, B and C were recently isolated from a marine Bacillus sp. bacterium and have shown cytotoxic activity against human colon tumour cells. The mixirins were identified as a mixture of cyclic lipopeptides belonging to the iturin family. The iturins contain seven alpha-amino acid residues (five proteinogenic and two D-amino acids) and one unusual lipophilic beta-amino acid residue. Until now, the mixirins have yet to be synthesised and have their pharmacotherapeutic potential fully explored. This report describes the development and optimisation of novel methodology to enantioselectively synthesise lipophilic beta-amino acids, and demonstrates this through the syntheses of the beta-amino acid constituents of the mixirins. This methodology can also be used as a general procedure for homologation of alpha-amino acids to the corresponding beta-amino acids. The synthesised beta-amino acids were then utilised in the first reported total syntheses of mixirins A, B and C using established SPPS techniques. The absolute configuration of the beta-amino acid component of the mixirins (which had not been reported) was suggested to be of the (R)-configuration from macrolactamisation studies. Eight novel compounds with potential anticancer activity have been synthesised: mixirins A, B and C, and the beta-amino acid epimer of each, along with two mixirin analogues containing a beta-amino acid residue of reduced lipophilicity. Early biological testing has demonstrated promising results, confirming their pharmacotherapeutic potential. A study was carried out to determine whether the biosynthetic site of lipopeptide cyclisation is the most efficient for use during SPPS. Iturin A was chosen as it is a cyclic lipopeptide possessing significant biological activity, its biosynthesis via NRPSs is well-studied, and its total solid-phase synthesis has not been reported. Out of six trials (each with a different ring-closure site), only four proved suitable for the routine and high yielding synthesis of iturin A. The remaining two proved less convenient due to difficulties in the initial residue side-chain immobilisation. Ring closure between D-Tyr-3 and Asn-2 proved most efficient. Further work should be undertaken to pursue this interesting hypothesis and to investigate whether SPPS can be optimised from biosynthetic knowledge.
机译:Mixirins A,B和C最近是从海洋芽孢杆菌中分离得到的。细菌并显示出对人结肠肿瘤细胞的细胞毒活性。混合蛋白被鉴定为属于iturin家族的环状脂肽的混合物。 Iturins包含七个α-氨基酸残基(五个蛋白原和两个D-氨基酸)和一个不寻常的亲脂性β-氨基酸残基。到现在为止,mixirins尚未合成,并且已经充分探索了它们的药物治疗潜力。该报告描述了对映选择性合成亲脂性β-氨基酸的新方法的开发和优化,并通过混合蛋白的β-氨基酸成分的合成证明了这一点。该方法也可以用作将α-氨基酸同源化为相应的β-氨基酸的一般方法。然后,使用已建立的SPPS技术,将合成的β-氨基酸用于混合色素A,B和C的首次报道的总合成中。根据大内酰胺化研究,认为混合蛋白的β-氨基酸组分的绝对构型(尚未报道)为(R)构型。已经合成了八种具有潜在抗癌活性的新型化合物:mixirins A,B和C,以及每种混合物的β-氨基酸差向异构体,以及两种含有降低亲脂性的β-氨基酸残基的mixirin类似物。早期的生物学测试已显示出令人鼓舞的结果,证实了它们的药物治疗潜力。进行了一项研究以确定脂肽环化的生物合成位点在SPPS期间是否最有效。选择伊图林A是因为它是具有显着生物学活性的环状脂肽,其通过NRPS的生物合成得到了很好的研究,尚未报道其总固相合成。在六项试验(每项试验均具有不同的闭环位点)中,只有四项被证明适合常规和高产率的iturin A合成。由于初始残基侧链固定困难,其余两项被证明不太方便。 D-Tyr-3和Asn-2之间的环闭合被证明是最有效的。应该采取进一步的工作来追求这一有趣的假设,并研究是否可以从生物合成知识中优化SPPS。

著录项

  • 作者

    Kemp, Gary Christopher.;

  • 作者单位

    University of London, University College London (United Kingdom).;

  • 授予单位 University of London, University College London (United Kingdom).;
  • 学科 Pharmaceutical sciences.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 287 p.
  • 总页数 287
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号